Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Obstructive sleep apnoea treatment and fasting lipids: a comparative effectiveness study.

Keenan BT, Maislin G, Sunwoo BY, Arnardottir ES, Jackson N, Olafsson I, Juliusson S, Schwab RJ, Gislason T, Benediktsdottir B, Pack AI.

Eur Respir J. 2014 Aug;44(2):405-14. doi: 10.1183/09031936.00043614. Epub 2014 May 15.

2.

Effects of Continuous Positive Airway Pressure on Lipidaemia and High-sensitivity C-reactive Protein Levels in Non-obese Patients with Coronary Artery Disease and Obstructive Sleep Apnoea.

Huang Z, Liu Z, Zhao Z, Zhao Q, Luo Q, Tang Y.

Heart Lung Circ. 2016 Jun;25(6):576-83. doi: 10.1016/j.hlc.2015.10.021. Epub 2016 Jan 4.

PMID:
26804247
3.

Effects of 8 weeks of CPAP on lipid-based oxidative markers in obstructive sleep apnea: a randomized trial.

Sivam S, Witting PK, Hoyos CM, Maw AM, Yee BJ, Grunstein RR, Phillips CL.

J Sleep Res. 2015 Jun;24(3):339-45. doi: 10.1111/jsr.12271. Epub 2014 Dec 22.

4.

[Long term effect of autoadjusting positive airway pressure on C-reactive protein and interleukin-6 in men with obstructive sleep apnoea syndrome].

Drummond M, Winck J, Guimarães J, Santos AC, Almeida J, Marques J.

Arch Bronconeumol. 2009 Dec;45(12):577-84. doi: 10.1016/j.arbres.2009.05.002. Epub 2009 Jun 23. Spanish.

5.

Obstructive sleep apnoea in obese adolescents and cardiometabolic risk markers.

Watson SE, Li Z, Tu W, Jalou H, Brubaker JL, Gupta S, Huber JN, Carroll A, Hannon TS.

Pediatr Obes. 2014 Dec;9(6):471-7. doi: 10.1111/j.2047-6310.2013.00198.x. Epub 2013 Sep 17.

6.

Obstructive sleep apnoea and its therapy influence high-density lipoprotein cholesterol serum levels.

Börgel J, Sanner BM, Bittlinsky A, Keskin F, Bartels NK, Buechner N, Huesing A, Rump LC, Mügge A.

Eur Respir J. 2006 Jan;27(1):121-7.

8.

Cardiovascular mortality in obstructive sleep apnoea treated with continuous positive airway pressure or oral appliance: an observational study.

Anandam A, Patil M, Akinnusi M, Jaoude P, El-Solh AA.

Respirology. 2013 Nov;18(8):1184-90. doi: 10.1111/resp.12140.

PMID:
23731062
9.

Association between lipid peroxidation and inflammation in obstructive sleep apnoea.

Minoguchi K, Yokoe T, Tanaka A, Ohta S, Hirano T, Yoshino G, O'Donnell CP, Adachi M.

Eur Respir J. 2006 Aug;28(2):378-85.

10.

Distinct severity stages of obstructive sleep apnoea are correlated with unique dyslipidaemia: large-scale observational study.

Guan J, Yi H, Zou J, Meng L, Tang X, Zhu H, Yu D, Zhou H, Su K, Yang M, Chen H, Shi Y, Wang Y, Wang J, Yin S; Shanghai Sleep Health Study Research Group.

Thorax. 2016 Apr;71(4):347-55. doi: 10.1136/thoraxjnl-2015-207403. Epub 2016 Feb 16.

11.

Diurnal changes and levels of fibrin generation are not altered by continuous positive airway pressure (CPAP) in obstructive sleep apnoea (OSA). A randomised, placebo-controlled crossover study.

McEwen BJ, Phillips CL, Morel-Kopp MC, Yee BJ, Sullivan DR, Ward CM, Tofler GH, Grunstein RR.

Thromb Haemost. 2012 Oct;108(4):701-9. Epub 2012 Aug 23. Erratum in: Thromb Haemost. 2013 Oct 31;110(5):1085.

PMID:
22918526
12.

Impact of effective versus sham continuous positive airway pressure on liver injury in obstructive sleep apnoea: Data from randomized trials.

Jullian-Desayes I, Tamisier R, Zarski JP, Aron-Wisnewsky J, Launois-Rollinat SH, Trocme C, Levy P, Joyeux-Faure M, Pepin JL.

Respirology. 2016 Feb;21(2):378-85. doi: 10.1111/resp.12672. Epub 2015 Nov 16.

13.

An assessment of oxidized LDL in the lipid profiles of patients with obstructive sleep apnea and its association with both hypertension and dyslipidemia, and the impact of treatment with CPAP.

Feres MC, Fonseca FA, Cintra FD, Mello-Fujita L, de Souza AL, De Martino MC, Tufik S, Poyares D.

Atherosclerosis. 2015 Aug;241(2):342-9. doi: 10.1016/j.atherosclerosis.2015.05.008. Epub 2015 May 23.

PMID:
26071656
14.

Quality of life among untreated sleep apnea patients compared with the general population and changes after treatment with positive airway pressure.

Bjornsdottir E, Keenan BT, Eysteinsdottir B, Arnardottir ES, Janson C, Gislason T, Sigurdsson JF, Kuna ST, Pack AI, Benediktsdottir B.

J Sleep Res. 2015 Jun;24(3):328-38. doi: 10.1111/jsr.12262. Epub 2014 Nov 27.

15.

Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome.

Dorkova Z, Petrasova D, Molcanyiova A, Popovnakova M, Tkacova R.

Chest. 2008 Oct;134(4):686-92. doi: 10.1378/chest.08-0556. Epub 2008 Jul 14.

PMID:
18625666
16.

Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment: a cohort study.

Campos-Rodriguez F, Martinez-Garcia MA, de la Cruz-Moron I, Almeida-Gonzalez C, Catalan-Serra P, Montserrat JM.

Ann Intern Med. 2012 Jan 17;156(2):115-22. doi: 10.7326/0003-4819-156-2-201201170-00006.

PMID:
22250142
17.

Prevalence of metabolic syndrome in a north Indian hospital-based population with obstructive sleep apnoea.

Agrawal S, Sharma SK, Sreenivas V, Lakshmy R.

Indian J Med Res. 2011 Nov;134(5):639-44. doi: 10.4103/0971-5916.90988.

18.

Association between the severity of obstructive sleep apnea and the ratio of low-density lipoprotein cholesterol to high-density lipoprotein cholesterol.

Kawano Y, Tamura A, Kadota J.

Metabolism. 2012 Feb;61(2):186-92. doi: 10.1016/j.metabol.2011.06.004. Epub 2011 Aug 4.

PMID:
21820142
19.

Lipid profile after long-term APAP in OSA patients.

Rebelo S, Drummond M, Marques JA.

Sleep Breath. 2015 Sep;19(3):931-7. doi: 10.1007/s11325-014-1095-5. Epub 2014 Dec 16.

PMID:
25510508
20.

Effects of apolipoprotein E genotype on serum lipids in obstructive sleep apnoea.

Tisko R, Sopkova Z, Habalova V, Dorkova Z, Slaba E, Javorsky M, Tkac I, Riha RL, Tkacova R.

Eur Respir J. 2014 Apr;43(4):1097-105. doi: 10.1183/09031936.00098513. Epub 2013 Nov 14.

Supplemental Content

Support Center